0001192482-19-000447.txt : 20191126
0001192482-19-000447.hdr.sgml : 20191126
20191126191855
ACCESSION NUMBER: 0001192482-19-000447
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191122
FILED AS OF DATE: 20191126
DATE AS OF CHANGE: 20191126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhang Junge
CENTRAL INDEX KEY: 0001790205
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36751
FILM NUMBER: 191252707
MAIL ADDRESS:
STREET 1: 5 GREAT VALLEY PARKWAY, SUITE 160
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocugen, Inc.
CENTRAL INDEX KEY: 0001372299
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 GREAT VALLEY PARKWAY
STREET 2: SUITE 160
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-328-4698
MAIL ADDRESS:
STREET 1: 5 GREAT VALLEY PARKWAY
STREET 2: SUITE 160
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: HISTOGENICS CORP
DATE OF NAME CHANGE: 20060810
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-11-22
0001372299
Ocugen, Inc.
OCGN
0001790205
Zhang Junge
C/O OCUGEN, INC. 5 GREAT VALLEY PARKWAY
SUITE 160
MALVERN
PA
19355
1
0
0
0
Common Stock
2019-11-22
4
P
0
80000
.28
A
215078
D
Common Stock
2019-11-25
4
P
0
115000
.27
A
330078
D
Common Stock
212863
I
By Gupiao Trust
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.27 to $0.28. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.26 to $0.27. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (2) to this Form 4.
/s/ Junge Zhang by Kelly Beck, his attorney-in-fact
2019-11-26